The global Endovascular Aneurysm Repair (EVAR) Market is on a strong growth trajectory, estimated at USD 3.3 billion in 2025 and projected to reach USD 5.3 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the forecast period. This robust expansion highlights the increasing adoption of minimally invasive aneurysm repair procedures worldwide, propelled by advancements in medical technology, rising awareness among patients and physicians, and expanding healthcare infrastructure.
EVAR, a minimally invasive technique used to treat abdominal aortic aneurysms (AAA), has emerged as a preferred alternative to traditional open surgery. Unlike conventional methods, EVAR reduces hospital stays, lowers procedural risks, and supports faster recovery, making it an attractive choice for both patients and healthcare providers. With the growing prevalence of AAAs, particularly among the geriatric population, the market is experiencing heightened demand across developed and emerging economies.
Regional Market Dynamics
Geographically, North America, Asia-Pacific, and Europe are the key growth regions for the EVAR market. In North America, the USA is expected to reach a valuation of USD 1.7 billion by 2035, growing at a CAGR of 4.1% from 2025.
Germany, leading Western Europe, is anticipated to maintain a CAGR of 5.5%, reflecting steady demand for minimally invasive vascular procedures. Emerging markets, notably China and India, are registering the highest growth rates of 6.5% and 6.0%, respectively, supported by increasing healthcare expenditure, expanding hospital networks, and government initiatives aimed at improving cardiovascular care.
Other markets such as Japan and South Korea are also contributing to the global landscape, with estimated valuations of USD 173.8 million and USD 98.5 million, respectively, in 2025. Brazil, while showing comparatively slower growth at a CAGR of 3.6%, still underscores a positive outlook for the EVAR market in Latin America. Overall, the market’s growth is fueled by increasing geriatric populations, higher awareness of minimally invasive interventions, and improved access to advanced medical technologies worldwide.
Driving Factors Behind Market Growth
Several factors are driving the EVAR market’s steady expansion. The rise in cardiovascular diseases globally, particularly abdominal aortic aneurysms, has significantly increased demand for minimally invasive solutions. Continuous technological advancements in stent graft design, imaging systems, and navigation tools are improving surgical precision, safety, and long-term outcomes, further encouraging adoption.
Patient-specific EVAR solutions and customized grafts are gaining prominence, as they allow clinicians to address anatomical variations that were previously challenging with standard procedures. These innovations have opened new avenues for treating high-risk patients, making EVAR a viable option for a broader patient base. Additionally, the integration of advanced imaging and real-time navigation tools is enhancing procedural efficiency, reducing complications, and enabling better clinical outcomes.
Government initiatives promoting early detection and preventive healthcare are also contributing to market growth. Increasing screening programs for at-risk populations, especially the elderly, ensure timely diagnosis and intervention, supporting the widespread adoption of EVAR. Rising healthcare expenditure, along with increasing investments from private and public sectors in research and development, is enabling the introduction of new technologies and devices, further strengthening market dynamics.
Competitive Landscape and Key Players
The EVAR market is characterized by the presence of both established multinational corporations and emerging players striving to expand their footprint through innovation and strategic collaborations. Leading companies such as Medtronic Plc, W. L. Gore & Associates Inc, Abbott Laboratories, Cardinal Health Inc, and Cook Medical continue to drive growth by introducing advanced stent grafts, fenestrated and branched EVAR solutions, and improved deployment systems.
Other notable participants, including Lombard Medical Inc, Endologix Inc, Becton, Dickinson and Company, Terumo Medical Corporation, and Koninklijke Philips N.V., are leveraging technological advancements and partnerships to broaden their market presence. Many of these players are investing in research and development to create patient-specific EVAR solutions, incorporate AI-enabled imaging and navigation tools, and enhance minimally invasive procedural outcomes.
Endovascular Aneurysm Repair (EVAR) Market by Segments
Techniques:
- Fenestrated EVAR
- Adjunctive EVARs
- Branched EVAR
- Percutaneous EVAR
- Hybrid Procedures
Demographics:
- Gender (Men And Women)
- Age (Paediatric, Adult And Geriatric)
Get Instant Access for Only $5,000 | Don’t Miss This Exclusive Offer!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2826
Checkout Now to Access Industry Insights:
https://www.futuremarketinsights.com/checkout/2826
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
